Nautic Partners has partnered with management to acquire QoL meds, a specialty pharmacy serving the mental health community.
QoL was founded in 2000 and is headquartered in Pittsburgh, Pennsylvania.
QoL operates specialty pharmacies across the country and dispenses over two million prescriptions and serves over 50,000 patients annually. QoL partners with mental health centres to integrate on-site pharmacy services in the delivery of care.
In addition to medication dispensing, QoL offers medication assistance and monitoring, outcomes and adherence reporting, customised packaging, patient education, assistance with reimbursement and clinical coordination, and 340b services. Over the last five years, QoL has grown from two pharmacies to 87 pharmacies.
“QoL has developed into one of the largest and most well-respected specialty pharmacies by delivering unmatched quality of care to its patients and clinical partners. QoL’s business model and approach to the delivery of care appropriately balances all constituents of healthcare which is a critical component of our healthcare investing model at Nautic,” says Chris Crosby, managing director of Nautic. “We are excited to be partnering with Jim Smith and the entire QoL team and believe that the company is well positioned for continued growth.”
“We are thrilled to partner with Nautic who shares our vision of growth and building the leading provider of specialty pharmacies for the behavioral health community,” said Jim Smith, president and CEO, QoL meds. “Nautic brings a wealth of healthcare investing experience, and we look forward to partnering with them to continue our mission of improving the Quality of Life for people living with mental illness by establishing a higher level of prescriptive care.”
QoL is Nautic Partners’ 14th investment from its most recent fund, Nautic Partners VI. Other representative Nautic healthcare investments include American Imaging Management, AXIA Health Management, Genova Diagnostics, Healthcare Payment Specialists, Medegen, Reliant Hospital Partners, Superior Vision and Theorem Clinical Research.
